Published: January 2013
|Formats||Member Price||Nonmember Price|
|Individual Download||$99 / €80||$405 / €330|
|Which format is right for me?|
Recent survey results show that the pharmaceutical companies often take an overly conservative approach to NIMPs (or Non-IMPs) due to regulatory and operational ambiguity. This can lead to unnecessary expenses and process steps, which can needlessly complicate clinical trials.
The ISPE Good Practice Guide: Harmonizing the Definition and Use of Non-Investigational Medicinal Products (NIMPs) aims to provide practical operational guidance and drive a consistent industry approach to the use of NIMPs. The Guide contains criteria for classifying NIMPs and an overview of current NIMP regulatory requirements.
This in-depth Guide will help you properly manage NIMPs by providing guidance on:
Creating Supply Chain Excellence, Achieving Superior Performance
Friday, 30 Sep 2016 15.09
Crucial Considerations: Disposable vs Stainless Steel Technology
Wednesday, 28 Sep 2016 16.09
GAMP: Cloud Computing Solutions & Providers Assessment & Management
Tuesday, 27 Sep 2016 16.09